Literature DB >> 20065134

Association of C-reactive protein with cognitive impairment.

James M Noble1, Jennifer J Manly, Nicole Schupf, Ming Xing Tang, Richard Mayeux, José A Luchsinger.   

Abstract

BACKGROUND: High-sensitivity C-reactive protein (hsCRP) is a biomarker of cardiovascular risk that is suggested to be a biomarker for cognitive impairment.
OBJECTIVE: To explore the association between hsCRP and cognitive impairment.
DESIGN: Cross-sectional analysis of a population-based community aging study.
SETTING: Northern Manhattan, New York, New York. OTHER PARTICIPANTS: One thousand three hundred thirty-one participants from a longitudinal study of aging without dementia and with available hsCRP and neuropsychological testing data at baseline. MAIN OUTCOME MEASURES: Four cognitive scores (memory, visuospatial, executive, and language impairment) derived from a neuropsychological battery. Cognitive impairment was defined by scores below 1.5 SDs of demographically corrected means.
RESULTS: Participants in the highest hsCRP tertile had higher adjusted odds of impaired memory (odds ratio [OR], 1.5; 95% confidence interval [CI], 1.0-2.1; P = .03) than participants in the lowest tertile. Subjects in the highest hsCRP tertile also had greater odds of visuospatial impairment (OR, 1.6; 95% CI, 1.0-2.3; P = .03). Higher hsCRP was not associated with executive or language impairment. Persons with at least 1 APOE epsilon4 allele and hsCRP in the highest tertile had the greatest odds of impaired memory (OR, 2.7; 95% CI, 1.6-4.4).
CONCLUSIONS: High hsCRP may be a marker of memory and visuospatial impairment in the elderly. The role of APOE epsilon4 requires further exploration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065134      PMCID: PMC4426905          DOI: 10.1001/archneurol.2009.308

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  47 in total

Review 1.  Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease.

Authors:  Richard A Frank; Douglas Galasko; Harald Hampel; John Hardy; Mony J de Leon; Pankaj D Mehta; Joseph Rogers; Eric Siemers; John Q Trojanowski
Journal:  Neurobiol Aging       Date:  2003 Jul-Aug       Impact factor: 4.673

Review 2.  Cardiovascular risk factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

3.  Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study.

Authors:  Hugh S Markus; Beverley Hunt; Kiran Palmer; Christian Enzinger; Helena Schmidt; Reinhold Schmidt
Journal:  Stroke       Date:  2005-05-19       Impact factor: 7.914

4.  Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Martina Chiappelli; Fausta Montesi; Emanuela Tumini; Erminia Mariani; Federico Licastro; Christopher Patterson
Journal:  Neurobiol Aging       Date:  2006-09-29       Impact factor: 4.673

5.  Endothelial function and white matter hyperintensities in older adults with cardiovascular disease.

Authors:  Karin F Hoth; David F Tate; Athena Poppas; Daniel E Forman; John Gunstad; David J Moser; Robert H Paul; Angela L Jefferson; Andreana P Haley; Ronald A Cohen
Journal:  Stroke       Date:  2007-01-04       Impact factor: 7.914

6.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

Review 7.  Inflammation and Alzheimer's disease.

Authors:  A Gupta; K Pansari
Journal:  Int J Clin Pract       Date:  2003 Jan-Feb       Impact factor: 2.503

8.  Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study.

Authors:  Edoardo Vicenzini; Maria Chiara Ricciardi; Marta Altieri; Francesco Puccinelli; Novella Bonaffini; Vittorio Di Piero; Gian Luigi Lenzi
Journal:  Eur Neurol       Date:  2007-06-12       Impact factor: 1.710

9.  C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.

Authors:  Mary N Haan; Allison E Aiello; Nancy A West; William J Jagust
Journal:  Neurobiol Aging       Date:  2007-05-30       Impact factor: 4.673

10.  Markers of inflammation and cognitive decline in an African-Caribbean population.

Authors:  Vesna Jordanova; Robert Stewart; Emma Davies; Roy Sherwood; Martin Prince
Journal:  Int J Geriatr Psychiatry       Date:  2007-10       Impact factor: 3.485

View more
  69 in total

Review 1.  Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.

Authors:  P Barberger-Gateau; C Samieri; C Féart; M Plourde
Journal:  Curr Alzheimer Res       Date:  2011-08       Impact factor: 3.498

2.  Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

Authors:  Thomas M van Himbergen; Alexa S Beiser; Masumi Ai; Sudha Seshadri; Seiko Otokozawa; Rhoda Au; Nuntakorn Thongtang; Philip A Wolf; Ernst J Schaefer
Journal:  Arch Neurol       Date:  2012-05

3.  Dietary Factors and Cognitive Decline.

Authors:  P J Smith; J A Blumenthal
Journal:  J Prev Alzheimers Dis       Date:  2016-03

Review 4.  Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.

Authors:  Anna C Hearps; Genevieve E Martin; Reena Rajasuriar; Suzanne M Crowe
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

Review 5.  Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.

Authors:  Eiron Cudaback; Nikolas L Jorstad; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Biochem Pharmacol       Date:  2014-01-13       Impact factor: 5.858

6.  Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment.

Authors:  James A Blumenthal; Patrick J Smith; Stephanie Mabe; Alan Hinderliter; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; Pao-Hwa Lin; William Kraus; P Murali Doraiswamy; James Burke; Andrew Sherwood
Journal:  Psychosom Med       Date:  2017 Jul/Aug       Impact factor: 4.312

7.  Cognitive dysfunction with aging and the role of inflammation.

Authors:  Arthur A Simen; Kelly A Bordner; Mark P Martin; Lawrence A Moy; Lisa C Barry
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

8.  How predictive of dementia are peripheral inflammatory markers in the elderly?

Authors:  Andrea L Metti; Jane A Cauley
Journal:  Neurodegener Dis Manag       Date:  2012-12-01

Review 9.  State of the science on prevention of elder abuse and lessons learned from child abuse and domestic violence prevention: Toward a conceptual framework for research.

Authors:  Jeanne A Teresi; David Burnes; Elizabeth A Skowron; Mary Ann Dutton; Laura Mosqueda; Mark S Lachs; Karl Pillemer
Journal:  J Elder Abuse Negl       Date:  2016-09-27

Review 10.  Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature.

Authors:  James M Noble; Nikolaos Scarmeas; Panos N Papapanou
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.